Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Performance and Cost-Effectiveness of Tumor Tissue-Modified Viral (TTMV)-Human Papillomavirus (HPV) DNA for Surveillance of HPV-Associated Oropharyngeal Squamous Cell Carcinoma.

A single-institution retrospective analysis assessed surveillance performance and cost of plasma TTMV-HPV DNA, alongside the three-month post-treatment PET scan, in HPV-associated oropharyngeal cancer.

CureusPubMed 42605455DOI 10.7759/cureus.112879